Cargando…
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease
BACKGROUND: Biological therapies have been introduced for the treatment of chronic inflammatory diseases including rheumatoid arthritis (RA) and Crohn's disease (CD). The efficacy of biologics differs from patient to patient. Moreover these therapies are rather expensive, therefore treatment of...
Autores principales: | Mesko, Bertalan, Poliska, Szilard, Váncsa, Andrea, Szekanecz, Zoltan, Palatka, Karoly, Hollo, Zsolt, Horvath, Attila, Steiner, Laszlo, Zahuczky, Gabor, Podani, Janos, Nagy, and Laszlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064310/ https://www.ncbi.nlm.nih.gov/pubmed/23809696 http://dx.doi.org/10.1186/gm463 |
Ejemplares similares
-
Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets
por: Mesko, Bertalan, et al.
Publicado: (2010) -
Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study
por: Miheller, Pál, et al.
Publicado: (2009) -
Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis
por: Póliska, Szilárd, et al.
Publicado: (2019) -
Patient and general population values for luminal and perianal fistulising Crohn’s disease health states
por: Rencz, Fanni, et al.
Publicado: (2019) -
Gene Expression Changes in Femoral Head Necrosis of Human Bone Tissue
por: Balla, Bernadett, et al.
Publicado: (2011)